AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Tilray, Inc. to Present at the 2020 ICR Conference

January 7, 2020 GMT

NANAIMO, British Columbia--(BUSINESS WIRE)--Jan 7, 2020--

Tilray, Inc., (“Tilray” or “the Company”) (Nasdaq: TLRY), a global leader in medical cannabis research, cultivation, production and distribution, today announced that Brendan Kennedy, President and Chief Executive Officer, will present at the 2020 ICR Conference.

The presentation will be on Tuesday, January 14, 2020 at 11:00 a.m. ET and the simultaneous, live webcast will be available on the Investors section of the Company’s website at www.tilray.com. The webcast will be archived for 30 days.

About Tilray®

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 15 countries spanning five continents.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200107006007/en/

CONTACT: Media: Chrissy Roebuck,+1-833-206-8161, news@tilray.com

Investors: Rachel Perkins, +1-646-277-1221,rachel.perkins@icrinc.com

KEYWORD: UNITED STATES NORTH AMERICA CANADA FLORIDA

INDUSTRY KEYWORD: ALTERNATIVE MEDICINE PHARMACEUTICAL HEALTH

SOURCE: Tilray, Inc.

Copyright Business Wire 2020.

PUB: 01/07/2020 04:05 PM/DISC: 01/07/2020 04:05 PM

http://www.businesswire.com/news/home/20200107006007/en